Back

Current LDL-cholesterol goals- Are they appropriate?

26 August 2018 (16:57 - 17:09)
Organised by:
Congress Presentation Part of: LDL goals and inflammation. From basic science to clinical practice. Risk Factors and Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkiye)

4 More presentations in this session

Presentation thumbnail
New aspects of the patho-biology of atherosclerosis: the role of lipids and inflammation.
Professor A. Catapano (Milan, IT)
Presentation thumbnail
Identification of new molecule to mediate binding of PCSK9 and LDL-receptor - New insight on action mechanism of PCSK9 to degrade LDL-R
Doctor H. Kim (Seoul, KR)
Presentation thumbnail
Future directions for research into LDL lowering, anti-inflammatory drugs and interactions.
Professor S. Kim (Seoul, KR)
Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
LDL goals and inflammation. From basic science to clinical practice.

The Event

Event poster

ESC Congress 2018

26 August 2018 16:57 CET
You may be interested in
thumbnail
Congress Presentation
The current LDL-C target <1.4mmol/l of the ESC is achieved in less than 16% of patients with Coronary Heart Disease despite effective lipid-lowering therapy: Data from the LLT-R registry
28 August 2020
thumbnail
Congress Session
Cardio-metabolic aspects of stroke and cerebrovascular disease
24 April 2026
thumbnail
Congress Session
Optimising cholesterol levels through dietary interventions: key strategies and evidence
23 June 2023
thumbnail
Congress Presentation
Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources